Biopharma Business

Tag "medical research"

Fungi have enormous potential for new antibiotics

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from

Read Full Article

LSTM reports on a new way of screening potential treatments for TB

Scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB)

Read Full Article

University of Dundee secures grant to discover new antibacterial drugs

University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to tackle bacterial infections. Antimicrobial resistance is one of the greatest

Read Full Article

Researchers Crack Structure of Key Protein in Zika Virus

Zika virus (ZIKV), which causes Zika virus disease, is spread to people primarily through the bite of an infected Aedes aegypti or Aedes albopictus mosquito. An infected pregnant woman can pass ZIKV to her

Read Full Article

Alzheimer’s disease linked to the metabolism of unsaturated fats

  A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with

Read Full Article

Dublin researchers discover way to prevent infections on medical devices

Researchers at Trinity College Dublin have discovered a way to prevent bacteria from growing on medical devices that are implanted in the human body.  The researchers state the discovery is

Read Full Article

Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer

Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form of skin cancer. After being acquired by Johnson & Johnson

Read Full Article

Gene Therapy Lets a French Teen Dodge Sickle Cell Disease

A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of

Read Full Article

Richmond Pharmacology opens new London research facility

Early-phase contract research organisation Richmond Pharmacology has opened its new research facility in London Bridge, at the site formerly known as the Guy’s Drug Research Unit. The organisation state that

Read Full Article

Dutch and German Biotechs enter the Clinic with their First Lanthipeptide

Lanthio Pharma has initiated a Phase I clinical trial with its lanthipeptide candidate MOR107, which is being developed as a therapy for diabetic nephropathy. Lanthio Pharma, a Dutch subsidiary of

Read Full Article

Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition with no cure. Modus Therapeutics, previously Dilaforette, is developing sevuparin,

Read Full Article

Liverpool Uni leads clinical trial of promising osteoarthritis drug

The University of Liverpool, in partnership with AKL Research and Development, will lead a clinical trial testing the potential of a new therapy for osteoarthritis (OA), the most common type

Read Full Article

Merck pulls plug on late-stage Alzheimer’s trial

Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate Alzheimer’s disease. The move came after an external data monitoring

Read Full Article

Encouraging clinical results for an antibody drug to prevent or treat HIV

A new biologic agent – the most potent of its kind so far – is showing early promise as part of a potential new strategy for treating HIV. The drug,

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here